Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Atossa Therapeutics Inc (NQ: ATOS ) 1.510 +0.120 (+8.63%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 894,702 Open 1.420 Bid (Size) 1.490 (10) Ask (Size) 1.500 (4) Prev. Close 1.390 Today's Range 1.400 - 1.510 52wk Range 0.6200 - 2.310 Shares Outstanding 125,785,200 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday September 11, 2024 Via Benzinga ATOS Stock Earnings: Atossa Therapeutics Beats EPS for Q2 2024 August 12, 2024 ATOS stock results show that Atossa Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Performance YTD +61.50% +61.50% 1 Month +11.85% +11.85% 3 Month +32.46% +32.46% 6 Month -16.11% -16.11% 1 Year +96.61% +96.61% More News Read More 3 Dirt-Cheap Drug Developers With Blockbuster Potential July 11, 2024 Via InvestorPlace 3 Penny Stock Moonshots with 300%+ Upside Potential by 2025 July 03, 2024 Via InvestorPlace Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar June 07, 2024 Via InvestorPlace MicroMarvel - Atossa Therapeutics April 06, 2024 Via Talk Markets Atossa Therapeutics backing Endoxifen in the fight against breast cancer August 23, 2023 Via News Direct 3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off May 20, 2024 Via InvestorPlace Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 May 17, 2024 Via InvestorPlace ATOS Stock Earnings: Atossa Therapeutics Beats EPS for Q1 2024 May 13, 2024 Via InvestorPlace Shhh! 3 Secret Penny Stocks Flying Below Wall Street’s Radar May 09, 2024 Via InvestorPlace ATOS Stock Earnings: Atossa Therapeutics Misses EPS for Q4 2023 April 01, 2024 Via InvestorPlace Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market January 16, 2024 Via InvestorPlace This Drug Developer Is Dedicated To "Transforming The Breast Cancer Paradigm" October 24, 2023 Via Benzinga Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers - Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment September 18, 2023 Via ACCESSWIRE Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers – Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment September 15, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session September 08, 2023 Via Benzinga Breast Cancer-Focused Atossa Therapeutics Can Possibly Change Treatment Paradigm: Analyst September 08, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session September 08, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023 September 08, 2023 Via Benzinga Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer? August 09, 2023 Via Benzinga 50% Of Women Have Elevated Breast Density, Which Significantly Decreases the Effectiveness of Mammography - Atossa Therapeutics Is Looking To Ensure Earlier, Accurate Diagnosis July 12, 2023 Via ACCESSWIRE 50% Of Women Have Elevated Breast Density, Which Significantly Decreases The Effectiveness Of Mammography – Atossa Therapeutics Is Looking To Ensure Earlier, Accurate Diagnosis July 11, 2023 Via Benzinga 3 Penny Stocks to Make Your ‘Get Rich’ Dreams Come True July 06, 2023 Via InvestorPlace 3 Penny Stocks Set to Pass the $5 Mark Soon June 23, 2023 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
